Proteostasis Raises $45 Million

Proteostasis Therapeutics Inc., a Cambridge, Mass.-based developer of small molecule therapeutics to control the body's protein homeostasis,, has raised $45 million in Series A funding. Backers include HealthCare Ventures, Fidelity Biosciences, New Enterprise Associates, Novartis Option Fund and Genzyme Ventures.


Proteostasis Therapeutics, Inc. (PTI) today announced that it has secured $45 million in a Series A financing to develop Proteostasis Regulator